• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

143.97 +7.35 (+5.38%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
99 100 Next >
News headline image
Why Moderna Stock Was Down 31.8% in Q1 as the S&P 500 Had Its Worst Quarter Since 2022 ↗
April 08, 2025
Via The Motley Fool
Topics Government Stocks
News headline image
Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025
April 07, 2025
Via ACCESS Newswire
News headline image
Spotting Winners: United Therapeutics (NASDAQ:UTHR) And Therapeutics Stocks In Q4
April 07, 2025
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at therapeutics stocks, starting with United... 
Via StockStory
Topics Artificial Intelligence
News headline image
Better Beaten-Down Stock to Buy: Pfizer Vs. Moderna ↗
April 03, 2025
Via The Motley Fool
Topics Intellectual Property
News headline image
Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks
April 03, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q4, starting with Amgen... 
Via StockStory
Topics Artificial Intelligence
News headline image
FDA News Just Shook Moderna. Is the Stock One to Avoid or a Bad-News Buy? ↗
April 03, 2025
Via The Motley Fool
News headline image
Retail Traders Mostly Bullish On Biotech Stocks Amid Blow From RFK Jr. Purge On Health Agencies ↗
April 02, 2025
The sector's recent slide follows Peter Marks' resignation last week as the Food and Drug Administration's top vaccine regulator following a clash with Kennedy. 
Via Stocktwits
Topics ETFs Government
News headline image
Uncover the latest developments among S&P500 stocks in today's session. ↗
April 01, 2025
Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
April 01, 2025
 
Via Benzinga
News headline image
Jim Cramer Asks Trump To Take Stock As Markets Swing Again Ahead Of 'Liberation Day' ↗
March 31, 2025
US Markets continued to witness volatility on Monday as President Donald Trump's 'Liberation Day' fast approaches, bringing a volley of tariffs across products, industries, allies, and adversaries.... 
Via Benzinga
Topics Government World Trade
News headline image
Nvidia, Moderna, Lucid, Dominari Holdings, Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗
March 31, 2025
The stock market faced a challenging day as risk sentiment remained under pressure on Wall Street. The S&P 500 experienced a volatile session, hitting its lowest point in over six months before... 
Via Benzinga
News headline image
What's going on in today's session: S&P500 movers ↗
March 31, 2025
Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session. 
Via Chartmill
News headline image
Moderna (MRNA) Stock Trades Down, Here Is Why
March 31, 2025
Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 12.5% in the morning session after Peter Marks, the head of the FDA's Center for Biologics Evaluation and Research (CBER), resigned on Friday,... 
Via StockStory
Topics Artificial Intelligence Government
News headline image
Exploring the top movers within the S&P500 index during today's session. ↗
March 31, 2025
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Monday. 
Via Chartmill
News headline image
Why Moderna Stock Is Plummeting Today ↗
March 31, 2025
Via The Motley Fool
Topics Government Stocks
News headline image
Stocks Fall, S&P 500 Eyes Worst Month In Almost Two Years, Oil Rallies: What's Driving Markets Monday? ↗
March 31, 2025
Risk sentiment remains under pressure at the start of the week on Wall Street, with tech-heavy indexes sliding while commodities advance, as traders fear a new wave of price pressures following the... 
Via Benzinga
Topics Stocks World Trade
News headline image
Nasdaq Continues Selloff, Eyes Worst Month Since 2022 ↗
March 31, 2025
All three major indexes are on track for monthly and quarterly losses. 
Via Talk Markets
Topics Stocks / Equities
News headline image
What's going on in today's session: S&P500 gap up and gap down stocks ↗
March 31, 2025
Curious about the market action on Monday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
News headline image
These S&P500 stocks that are showing activity before the opening bell on Monday. ↗
March 31, 2025
Wondering what's happening in today's pre-market session? Stay tuned for the latest updates on S&P500 stock movements. 
Via Chartmill
News headline image
Moderna, Novavax Shares Are Tumbling Monday: What's Going On? ↗
March 31, 2025
Vaccine stocks are trading lower Monday following a shakeup at the U.S. Food and Drug Administration. 
Via Benzinga
News headline image
Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks Resigns ↗
March 31, 2025
Peter Marks heads up the department in charge of reviewing vaccines, genetic medicines and cell therapies. 
Via Investor's Business Daily
News headline image
Peering Into Moderna's Recent Short Interest ↗
March 31, 2025
 
Via Benzinga
News headline image
Moderna Receives Australian Therapeutic Goods Administration Approval for RSV Vaccine for Older Adults
March 31, 2025
Via ACCESS Newswire
News headline image
10 Worst Performing Large-Caps Last 12 Months ↗
March 27, 2025
Here’s this week’s top 10 worst performing Large-Caps in the last twelve months. 
Via Talk Markets
Topics Stocks / Equities
News headline image
What's going on in today's session: S&P500 movers ↗
March 26, 2025
Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
News headline image
Moderna, Novavax Shares Are Sliding Wednesday: What's Going On? ↗
March 26, 2025
Vaccine makers Moderna Inc (NASDAQ:MRNA) and Novavax Inc (NASDAQ:NVAX) are facing selling pressure on Wednesday following reports suggesting the Trump administration will end support for Gavi. 
Via Benzinga
Topics Government
News headline image
Which S&P500 stocks are gapping on Wednesday? ↗
March 26, 2025
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Wednesday. Stay informed about the latest market trends. 
Via Chartmill
News headline image
Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks
March 24, 2025
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Moderna (NASDAQ:MRNA) and the best and worst... 
Via StockStory
Topics Artificial Intelligence
News headline image
XPeng, Reddit And Micron Tech Are Among Top 10 Large-Cap Losers Last Week (Mar 17-Mar 21): Are The Others In Your Portfolio? ↗
March 23, 2025
Large-cap stocks worst performers last week, including BEKE, RDDT, FUTU, JHX, INCY, NUE, BAH, XPEV, MRNA, TU, WLK. Are they in your portfolio? 
Via Benzinga
News headline image
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move ↗
March 22, 2025
Via The Motley Fool
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap